Virginie Desestret Selected Research

Ischemic Stroke

1/2007

USPIO-enhanced MRI of neuroinflammation at the sub-acute stage of ischemic stroke: preliminary data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginie Desestret Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 12/2010
14	Encephalitis (Encephalitis, Rasmussen) 12/2023 - 02/2014
6	Autoimmune Diseases of the Nervous System 10/2018 - 05/2014
5	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023 - 01/2016
4	Paraneoplastic Cerebellar Degeneration 02/2023 - 01/2018
4	Glioma (Gliomas) 01/2022 - 12/2010
3	Ataxia (Dyssynergia) 02/2023 - 07/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2018
3	Cerebellar Ataxia (Dysmetria) 01/2022 - 07/2017
3	Stroke (Strokes) 01/2013 - 05/2009
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 01/2023
2	Inflammation (Inflammations) 01/2022 - 04/2019
2	Nervous System Paraneoplastic Syndromes 01/2020 - 11/2019
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 11/2019
2	Tertiary Lymphoid Structures 11/2019 - 01/2018
2	Teratoma (Teratoid Tumor) 11/2019 - 12/2015
2	Seizures (Absence Seizure) 05/2018 - 01/2016
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 10/2016 - 12/2015
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2009 - 01/2007
1	Carcinoma (Carcinomatosis) 02/2023
1	Normal Pressure Hydrocephalus 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Leukocytosis (Pleocytosis) 10/2021
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2021
1	Paralysis (Palsy) 01/2021
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021
1	Optic Nerve Diseases (Optic Neuropathy) 01/2021
1	Temporal Lobe Epilepsy 07/2020
1	Mesothelioma 11/2019
1	Adenocarcinoma of Lung 04/2019
1	Cognitive Dysfunction 05/2018
1	Mental Disorders (Mental Disorder) 05/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Dysarthria (Spastic Dysarthria) 07/2017
1	Asthenia 01/2017
1	Anterograde Amnesia 01/2017
1	Muscle Rigidity 10/2016
1	Neurologic Manifestations (Neurological Manifestations) 10/2016
1	Rhabdomyolysis 10/2016
1	Mutism (Selective Mutism) 10/2016
1	Coma (Comas) 10/2016
1	Thymoma (Thymic Carcinoma) 01/2016
1	Isaacs Syndrome (Neuromyotonia) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Ovarian Teratoma 12/2015
1	Infectious Encephalitis 05/2014
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Leiomyosarcoma 05/2013
1	Neoplasm Metastasis (Metastasis) 05/2013
1	Brain Ischemia (Cerebral Ischemia) 01/2013
1	Infarction (Infarctions) 01/2013

Drug/Important Bio-Agent (IBA)

15	AntibodiesIBA 01/2023 - 02/2014
8	AutoantibodiesIBA 01/2024 - 05/2014
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2014
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2019 - 02/2014
5	AntigensIBA 01/2024 - 01/2018
5	anti-Yo autoantibodiesIBA 02/2023 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2019
3	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 05/2009 - 01/2007
2	Leucine (L-Leucine)FDA Link 01/2022 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
2	Oligoclonal BandsIBA 10/2021 - 04/2019
2	adenylate kinase 5IBA 10/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 11/2019 - 12/2015
2	Immunoglobulin A (IgA)IBA 11/2019 - 12/2015
2	AutoantigensIBA 01/2018 - 01/2017
2	ferric oxide (iron oxide)IBA 01/2013 - 01/2007
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2011 - 12/2010
1	InterferonsIBA 12/2023
1	N 30IBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	AD 20 (AD-20)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	IpilimumabIBA 11/2019
1	pembrolizumabIBA 11/2019
1	NivolumabIBA 11/2019
1	Tripartite Motif ProteinsIBA 04/2019
1	N-Methylaspartate (NMDA)IBA 05/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 10/2016
1	Surface Antigens (Surface Antigen)IBA 01/2016
1	AcidsIBA 10/2015
1	AMPA Receptors (AMPA Receptor)IBA 10/2015
1	Estrogen ReceptorsIBA 05/2013
1	FSH Receptors (FSH Receptor)IBA 05/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2013
1	Monoclonal AntibodiesIBA 05/2013
1	Therapeutic UsesIBA 01/2013
1	alpha-internexinIBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2010
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2009
1	IronIBA 05/2009

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2013
2	Immunotherapy 10/2021 - 01/2017
1	Aftercare (After-Treatment) 11/2019